Association of influenza incidence with multiple sclerosis onset

Folia Neuropathologica

Volumn 42, Issue 1, 2004, Pages 19-24

  Kaźmierski, Radosław ^a   Wender, Mieczysław ^b   Guzik, Przemysław ^a   Zielonka, Daniel ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Environmental factors; Epidemiology; Influenza; Multiple sclerosis; Viral infections

Indexed keywords

AIR POLLUTION; ARTICLE; CHICKENPOX; CLIMATE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HUMAN; INCIDENCE; INFLUENZA; MAJOR CLINICAL STUDY; MEASLES; MULTIPLE SCLEROSIS; MUMPS; POLAND; POPULATION RESEARCH; RUBELLA; STATISTICAL ANALYSIS; VIRUS INFECTION;

EID: 1942485329     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Andersen O, Lygner PE, Bergstrom T (1993) Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol, 240: 417-422.
2. Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, Hankinson SE, Hunter DJ (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis. JAMA, 286: 3083-3088.
3. Bansil S, Troiano R, Dowling PC, Cook SD (1990) Measles vaccination does not prevent multiple sclerosis. Neuroepidemiology, 9: 248-254.
4. Boman J, Roblin PM, Sundstrom P, Sandstrom M, Hammerschlag MR (2000) Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology, 54: 265-266.
5. Cendrowski W, Wender M, Dominik W, Fleisierowicz Z, Owsianowski M, Popiel M (1969) Epidemiological study of multiple sclerosis in western Poland. Europ Neurol, 2: 90-108.
6. Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S, for the Vaccines in Multiple Sclerosis Study Group (2001) Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med., 344: 319-326.
7. Dhib-Jalbut S, Lewis K, Bradburn E, McFarlin DE, Mc Farland HF (1990) Measles virus polypeptyde-specific antibody profile in multiple sclerosis. Neurology, 40: 1430-1435.
8. Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H (1998) Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet, 351: 33.
9. Kurtzke JF, Gudmundsson KR, Bergmann S (1982) Multiple sclerosis in Iceland: 1. Evidence of postwar epidemic. Neurology, 32: 143-150.
10. Kurtzke JF, Hyllested K (1979) Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Ann Neurol, 5: 6-21.
11. Kurtzke JF, Hyllested K (1986) Multiple sclerosis in the Faroe Islands: II. Clinical update, transmission, and the nature of MS. Neurology, 36: 301-328.
12. Kurtzke JF, Hyllested K, Heltberg A, Olsen A (1993) Multiple sclerosis in the Faroe Islands. 5. The occurrence of the forth epidemic as validation of transmission. Acta Neurol Scand, 88: 161-173.
13. Marrie RA, Wolfson C, Sturkenboom MCJM, Gout O, Heinzlef O, Roullet E, Abenhaim L (2000) Multiple sclerosis and antecedent infections: a case-control study. Neurology, 54: 2307-2310.
14. Moriabadi N, Niewiesk S, Kruse N, Jung S, Weissbrich B, ter Meulen V, Toyka KV, Rieckmann P (2001) Influenza vaccination in MS. Neurology, 56: 938-943.
15. Ongradi J, Rajda C, Marodi CL, Csiszar A, Vecsei L (1999) A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. J Neurovirol, 5: 529-532.
16. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol, 13: 227-231.
17. Rosati G, Aiello E, Granieri E, Pirastru MI, Becciu S, Demontis G, Mannu L, Zoccheddu A (1986) Incidence of multiple sclerosis in Macomer, Sardinia, 1912-1981: onset of the disease after 1950. Neurology, 36: 14-19.
18. Rotola A, Cassai E, Tola MR, Graranieri E, Di Luca D (1999) Human herpesvirus 6 is latent in peripherial blood of patients with relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry, 67: 529-531.
19. Sadovnick AD, Ebers GC (1993) Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci, 20: 17-29.
20. Sibley WA, Bamford CR, Clark K (1985) Clinical viral infections and multiple sclerosis. Lancet, 1: 1313-1315.
21. Sriram S, Stratton CW, Yao S, Tharp A, Ding L, Bannan JD (1999) Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol, 46: 1-4.
22. Summers BA, Appel MJ (1994) Aspects of canine distemper virus and measles virus encephalomyelitis. Neuropathol Appl Neurobiol, 20: 525-534.
23. Wender M, Kaźmierski R (1994) The descriptive and analytical epidemiology of multiple sclerosis in western Poland. In: Firnhaber W, Lauer K (eds) Multiple Sclerosis in Europe. An Epidemiological Update. Leuchtturm-Verlag/LTV Press Darmstadt: 241-248.
24. Wender M, Kowal P, Pruchnik-Grabowska D, Hertmanowska H, Marcinkowski J, Zielinska M, Namysł I (1985) The clustering of multiple sclerosis in various administrative subunits of western Poland. J Neurol, 232: 240-245.
25. Wender M, Pruchnik-Grabowska D, Hertmanowska H, Kowal P., Zielinska M, Namysł I, Marcinkowski J (1985) Epidemiology of multiple sclerosis in Western Poland - a comparision between prevalence rates in 1965 and 1981. Acta Neurol Scand, 72: 210-217.